Clinical Trial

Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2025 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to compare the clinical effect of Jinfeng Pill and Diane-35 in patients with PCOS. The main questions it aims to answer are: a. Comparison of the efficacy of the drugs separately and in combination. To explore the possible mechanism of Jinfeng pills. Participants will be treated for three months with monthly follow-up. Blood and stool samples should be collected.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06823830
Lead Sponsor Peking Union Medical College Hospital
Conditions Polycystic Ovary Syndrome
Enrollment 105 participants
Start Date 2023-09-01
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-02-12